Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer
Status:
Unknown status
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether setting test groups of cisplatin + irinotecan
+ Krestin therapy as first-line treatment and chemotherapy (radiotherapy or radiotherapy +
chemotherapy also allowed) combined with Krestin as second-line treatment after exacerbation
and comparing with historical control or community control is appropriate as the protocol and
regimen for the phase III clinical trial on extensive-stage disease (ED) small cell lung
cancer.